+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 243 Pages
  • October 2024
  • Region: Global
  • GlobalData
  • ID: 5923752
The Medical Devices sector report, “Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Hematological Disorders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hematological Disorders includes Hematology tests and Hemostasis tests segments. Laboratory Tests Laboratory Tests are any tests that require transporting of patient samples to a laboratory, including those with rapid turnaround times, are defined as laboratory or lab-based tests.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hematological Disorders under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hematological Disorders and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hematological Disorders under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Hematological Disorders Overview
3 Products under Development
3.1 Hematological Disorders - Pipeline Products by Stage of Development
3.2 Hematological Disorders - Pipeline Products by Segment
3.3 Hematological Disorders - Pipeline Products by Territory
3.4 Hematological Disorders - Pipeline Products by Regulatory Path
3.5 Hematological Disorders - Pipeline Products by Estimated Approval Date
3.6 Hematological Disorders - Ongoing Clinical Trials
4 Hematological Disorders - Pipeline Products under Development by Companies
4.1 Hematological Disorders Companies - Pipeline Products by Stage of Development
4.2 Hematological Disorders - Pipeline Products by Stage of Development
5 Hematological Disorders Companies and Product Overview6 Hematological Disorders- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Hematological Disorders - Pipeline Products by Stage of Development
  • Hematological Disorders - Pipeline Products by Segment
  • Hematological Disorders - Pipeline Products by Territory
  • Hematological Disorders - Pipeline Products by Regulatory Path
  • Hematological Disorders - Pipeline Products by Estimated Approval Date
  • Hematological Disorders - Ongoing Clinical Trials
  • Hematological Disorders Companies - Pipeline Products by Stage of Development
  • Hematological Disorders - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Hematological Disorders - Pipeline Products by Stage of Development
  • Hematological Disorders - Pipeline Products by Segment
  • Hematological Disorders - Pipeline Products by Territory
  • Hematological Disorders - Pipeline Products by Regulatory Path
  • Hematological Disorders - Pipeline Products by Estimated Approval Date
  • Hematological Disorders - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abionic SA
  • Abram Scientific Inc
  • Analyticon Biotechnologies AG
  • Aptitude Medical Systems Inc
  • Atantares Corp
  • Atomo Diagnostics Ltd
  • Baebies Inc
  • Beckman Coulter Inc
  • Beijing Sailing Medical Technology Co Ltd
  • Bio Vitos Pharma AB
  • Biochip Labs Inc
  • BioMedica USA LLC (Inactive)
  • BioMedomics Inc
  • Biosurfit, SA
  • Braun Biosystems, Inc. (Inactive)
  • Carclo Diagnostic Solutions Ltd
  • Coramed Technologies, LLC
  • Diagnostica Stago Inc
  • Duke University
  • DxDiscovery Inc
  • Dynasil Corporation of America
  • Edan Instruments Inc
  • EKF Diagnostics Holdings Plc
  • ELITechGroup Inc
  • Emosis SAS
  • Epimune GmbH
  • Epinex Diagnostics Inc
  • ET Healthcare Inc
  • Flobio LLC
  • Fraunhofer Institute for Cell Therapy and Immunology
  • genedrive plc
  • Grifols SA
  • Group K Diagnostics
  • Guangzhou Wondfo Biotech Co Ltd
  • Hansjorg Wyss Institute for Biologically Inspired Engineering
  • Helena Laboratories Corp
  • Hemex Health Inc
  • HemoSonics LLC
  • Immunostep S.L
  • Instrumentation Laboratory Co (Inactive)
  • IntraMed Diagnostics, LLC
  • Inverness Medical Canada Inc. (Inactive)
  • Levisonics Inc
  • Massachusetts General Hospital
  • McMaster University
  • MiCo BioMed Co Ltd
  • Novametics Inc (Inactive)
  • Ohio State University
  • Optolane Technologies Inc
  • Pakwa Technologies
  • Perosphere Technologies Inc
  • PortaScience Inc
  • Prolight Diagnostics AB
  • QSTAG Co Ltd
  • Radiometer Medical ApS
  • Randox Laboratories Ltd
  • Rappaport Family Institute for Research in the Medical Science
  • Retham Technologies LLC
  • rHealth
  • Roche Diagnostics International Ltd
  • Sanguina LLC
  • Sekisui Diagnostics LLC
  • ShanMukha Innovations Pvt Ltd
  • Siemens Healthcare Diagnostics GmbH
  • Siemens Healthcare Diagnostics Inc
  • Siemens Healthineers AG
  • Silver Lake Research Corporation
  • SonoMedix, Inc.
  • SpinChip Diagnostics AS
  • SQI Diagnostics Inc
  • Stichting Lygature
  • T2 Biosystems Inc
  • The Binding Site Group Ltd
  • ThromboTherapeutics Inc
  • Tosoh Bioscience Inc
  • Transfusion & Transplantation Technologies (Inactive)
  • Universal Biosensors Inc
  • University of Burdwan
  • University of California Irvine
  • University of Colorado
  • University of Colorado Anschutz Medical Campus
  • University of Melbourne
  • University of Michigan
  • University of Texas Health Science Center at Houston
  • University of Vermont
  • University of Washington
  • VitaMe Technologies Inc